Why Disclosure Assessments Are The First Step To Improvement

Whether your organization lacks formal clinical trial data disclosure policies and procedures or has longstanding SOPs in place, just how efficient is your disclosure process?

That’s the question that UCB answered with a third-party compliance assessment, reviewing clinical trial disclosure requirements specific to the FDAAA Final Rule, and an assessment of study records and related SOPs. Join us for an informational webinar as Liz Roberts of UCB shares insights on her organization’s decision to commission a compliance assessment focused on the FDAAA/Final Rule requirements and the outcome of that assessment.